Louis C. Lucido - Mar 28, 2024 Form 4 Insider Report for BioCorRx Inc. (BICX)

Signature
/s/ Louis C. Lucido
Stock symbol
BICX
Transactions as of
Mar 28, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 09:00 AM
Previous filing
Mar 7, 2024
Next filing
May 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BICX Common Stock, par value $0.001 Award $0 +5.57K +1.09% $0.00 516K Mar 28, 2024 Direct F1
transaction BICX Common Stock, par value $0.001 Award $0 +18.6K +3.6% $0.00 534K Mar 28, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the "Company") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the "Common Stock") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90.
F2 These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the "Agreement"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90.